D. Errante

2.1k total citations
45 papers, 1.4k citations indexed

About

D. Errante is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, D. Errante has authored 45 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 29 papers in Pathology and Forensic Medicine and 13 papers in Genetics. Recurrent topics in D. Errante's work include Lymphoma Diagnosis and Treatment (25 papers), Viral-associated cancers and disorders (24 papers) and Chronic Lymphocytic Leukemia Research (12 papers). D. Errante is often cited by papers focused on Lymphoma Diagnosis and Treatment (25 papers), Viral-associated cancers and disorders (24 papers) and Chronic Lymphocytic Leukemia Research (12 papers). D. Errante collaborates with scholars based in Italy, Ukraine and United Kingdom. D. Errante's co-authors include Umberto Tirelli, Antonino Carbone, Emanuela Vaccher, Diego Serraino, S. Monfardini, Vittorina Zagonel, Renato Talamini, Michele Spina, Giuseppe Toffoli and Erika Cecchin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

D. Errante

45 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Errante Italy 20 1.1k 759 272 246 226 45 1.4k
D Schlaifer France 22 906 0.8× 796 1.0× 217 0.8× 247 1.0× 436 1.9× 52 1.6k
Milayna Subar United States 17 1.1k 1.0× 690 0.9× 141 0.5× 267 1.1× 90 0.4× 33 1.6k
R. Arranz Spain 21 861 0.8× 717 0.9× 146 0.5× 264 1.1× 119 0.5× 42 1.5k
Tanin Intragumtornchai Thailand 18 715 0.7× 833 1.1× 157 0.6× 186 0.8× 202 0.9× 67 1.5k
Patrizio Mazza Italy 22 680 0.6× 1.1k 1.4× 387 1.4× 516 2.1× 109 0.5× 98 1.8k
Wing‐Yan Au China 22 710 0.7× 747 1.0× 134 0.5× 197 0.8× 272 1.2× 44 1.9k
Burhan Ferhanoğlu Türkiye 14 453 0.4× 505 0.7× 118 0.4× 262 1.1× 109 0.5× 78 1.1k
Rika Sakai Japan 24 526 0.5× 581 0.8× 196 0.7× 370 1.5× 129 0.6× 107 1.5k
Mathias Hänel Germany 21 675 0.6× 814 1.1× 355 1.3× 484 2.0× 247 1.1× 72 1.8k
H. Wandt Germany 21 596 0.6× 495 0.7× 259 1.0× 382 1.6× 262 1.2× 48 1.9k

Countries citing papers authored by D. Errante

Since Specialization
Citations

This map shows the geographic impact of D. Errante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Errante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Errante more than expected).

Fields of papers citing papers by D. Errante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Errante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Errante. The network helps show where D. Errante may publish in the future.

Co-authorship network of co-authors of D. Errante

This figure shows the co-authorship network connecting the top 25 collaborators of D. Errante. A scholar is included among the top collaborators of D. Errante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Errante. D. Errante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garziera, Marica, Ettore Bidoli, Erika Cecchin, et al.. (2015). HLA-G 3'UTR +2960 14-bp INDEL (Ins/Del) polymorphism is associated to improved DFS of stage II-III CRC patients. Annals of Oncology. 26. vi43–vi43. 1 indexed citations
2.
Garziera, Marica, Ettore Bidoli, Erika Cecchin, et al.. (2015). HLA-G 3’UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment. PLoS ONE. 10(12). e0144000–e0144000. 28 indexed citations
3.
Cecchin, Erika, Mario D’Andrea, Sara Lonardi, et al.. (2012). A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen. The Pharmacogenomics Journal. 13(5). 403–409. 64 indexed citations
4.
Bernardi, Daniela, D. Errante, Enzo Galligioni, et al.. (2008). Treatment of breast cancer in older women. Acta Oncologica. 47(2). 187–198. 29 indexed citations
5.
6.
Nasti, Guglielmo, et al.. (1999). A Risk and Benefit Assessment of Treatment for AIDS-Related Kaposi??s Sarcoma. Drug Safety. 20(5). 403–425. 22 indexed citations
7.
Tirelli, Umberto, Vittorina Zagonel, D. Errante, Lucia Fratino, & S. Monfardini. (1998). Treatment of non-Hodgkin's lymphoma in the elderly: an update. Hematological Oncology. 16(1). 1–13. 12 indexed citations
8.
Nasti, Guglielmo, Emanuela Vaccher, D. Errante, & Umberto Tirelli. (1997). Malignant tumors and AIDS. Biomedicine & Pharmacotherapy. 51(6-7). 243–251. 11 indexed citations
9.
Vaccher, Emanuela, Umberto Tirelli, Michele Spina, et al.. (1996). Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.. Journal of Clinical Oncology. 14(8). 2217–2223. 57 indexed citations
10.
11.
Tirelli, Umberto, et al.. (1996). Malignant Lymphomas in Patients with HIV Infection. Leukemia & lymphoma. 22(3-4). 245–257. 9 indexed citations
12.
Tirelli, Umberto, et al.. (1996). Malignant tumors in patients with HIV infection. Critical Reviews in Oncology/Hematology. 24(3). 165–184. 3 indexed citations
13.
Tirelli, Umberto, D. Errante, Riccardo Dolcetti, et al.. (1995). Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.. Journal of Clinical Oncology. 13(7). 1758–1767. 163 indexed citations
14.
Angelis, Valentina De, et al.. (1995). Mixed‐Type Auto‐Immune Haemolytic Anaemia in a Patient with HIV Infection. Vox Sanguinis. 68(3). 191–194. 11 indexed citations
15.
Errante, D., Vittorina Zagonel, Emanuela Vaccher, et al.. (1994). Hodgkin's disease in patients with HIV infection and in the general population: Comparison of clinicopathological features and survival. Annals of Oncology. 5. S37–S40. 18 indexed citations
16.
Tirelli, Umberto, D. Errante, Emanuela Vaccher, et al.. (1992). Hodgkin's disease in 92 patients with HIV infection: The Italian experience. Annals of Oncology. 3. S69–S72. 50 indexed citations
17.
Serraino, Diego, et al.. (1992). Condom use and sexual habits of heterosexual intravenous drug users in Northern Italy. European Journal of Epidemiology. 8(5). 723–729. 3 indexed citations
18.
Frustaci, S., Andrea Freschi, Re G, et al.. (1992). Feasibility and efficacy of arginine 2-mercaptoethanesulfonate (ARGIMESNA) in the prevention of hemorragic cystitis from ifosfamide (IFO). Annals of Oncology. 3. S115–S118. 2 indexed citations
19.
Errante, D., Roberto Sorio, Vittorina Zagonel, et al.. (1991). A Phase II Study of Oral Idarubicin (4-Demethoxidaunorubicin) in Previously Untreated Elderly Patients with Non-Hodgkinʼs Lymphoma. American Journal of Clinical Oncology. 14(3). 243–245. 22 indexed citations
20.
Figoli, F., Andrea Veronesi, Marco Trovò, et al.. (1989). Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 24(6). 381–5. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Schlaifer Breakdown of academic impact, for papers by Milayna Subar Breakdown of academic impact, for papers by R. Arranz Breakdown of academic impact, for papers by Tanin Intragumtornchai Breakdown of academic impact, for papers by Patrizio Mazza Breakdown of academic impact, for papers by Wing‐Yan Au Breakdown of academic impact, for papers by Burhan Ferhanoğlu Breakdown of academic impact, for papers by Rika Sakai Breakdown of academic impact, for papers by Mathias Hänel Breakdown of academic impact, for papers by H. Wandt
Rankless by CCL
2026